
Procter & Gamble Health Ltd is Rated Sell
2026-04-28 10:10:03Procter & Gamble Health Ltd is rated Sell by MarketsMOJO. This rating was last updated on 07 Jan 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 28 April 2026, providing investors with the latest view on the company’s performance and prospects.
Read full news article
Procter & Gamble Health Ltd is Rated Sell
2026-04-17 10:10:03Procter & Gamble Health Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Procter & Gamble Health Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-04-17 08:01:07Procter & Gamble Health Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest day gain of 1.24%, the stock’s technical indicators reveal a cautious outlook, with recent downgrades and mixed momentum trends challenging investor sentiment.
Read full news article
Procter & Gamble Health Ltd is Rated Sell
2026-04-06 10:10:03Procter & Gamble Health Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Markets Rally, But Procter & Gamble Health Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-04-06 09:36:52While broader indices showed resilience, Procter & Gamble Health Ltd slipped to a fresh 52-week low of Rs 4,699.7 on 6 Apr 2026, marking a notable divergence from market trends and raising questions about the underlying factors driving this decline.
Read full news article
Markets Rally, But Procter & Gamble Health Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-04-02 09:39:17Despite a broader market rebound, Procter & Gamble Health Ltd has slipped to a fresh 52-week low of Rs 4,725.05 on 2 Apr 2026, marking a notable divergence from sector and benchmark trends.
Read full news article
Procter & Gamble Health Ltd is Rated Sell
2026-03-26 10:10:02Procter & Gamble Health Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Procter & Gamble Health Ltd Stock Falls to 52-Week Low of Rs 4740
2026-03-16 10:32:24Procter & Gamble Health Ltd has reached a new 52-week low of Rs.4740, marking a significant decline amid broader market weakness and persistent underperformance relative to its sector and benchmark indices.
Read full news article
Procter & Gamble Health Ltd is Rated Sell
2026-03-15 10:10:02Procter & Gamble Health Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news articleProcter & Gamble Health Limited - Updates
14-Nov-2019 | Source : NSEProcter & Gamble Health Limited has informed the Exchange regarding 'Updation of Company's and Investor's Helpline numbers'.
Procter & Gamble Health Limited - Outcome of Board Meeting
08-Nov-2019 | Source : NSEProcter & Gamble Health Limited has informed the Exchange regarding Board meeting held on November 07, 2019.
Related Party Transactions
06-Sep-2019 | Source : NSE
| Procter & Gamble Health Limited has informed the Exchange that regarding Related Party Transactions for six months ended June 30, 2019. |
Corporate Actions
26 May 2026
Procter & Gamble Health Ltd has declared 1100% dividend, ex-date: 12 Feb 26
No Splits history available
No Bonus history available
No Rights history available






